“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals” (2022) Journal of Pharmaceutical Negative Results, pp. 921–929. Available at: https://www.pnrjournal.com/index.php/home/article/view/3403 (Accessed: 6 June 2026).